Article

Active Surveillance of Prostate Cancer

Prostate cancer is the most common serious cancer in men and the second most common cause of death from cancer.

Prostate cancer is the most common serious cancer in men and the second most common cause of death from cancer. One in six men will be diagnosed with it during their lifetime resulting in about 200,000 new cases during the next 12 months. Despite the number of men affected, the prevention, diagnosis, and treatment of this disease probably are more controversial than any other cancer. Prostate Cancer: Reducing Your Risks explains both sides of the various controversies in an easy to understand manner. It provides you with balanced, unbiased information based on the best scientific studies available. Equipped with this information, you will be able to decide the best course of action to maximize your survival and your quality of life.

Related Videos
The APAC Recap: Cardiomyopathy at CAPP Live 2024 with Greg Duck, PA-C | Image Credit: APAC
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
The APAC Recap: Peripheral Artery Disease at CAPP Live 2024 with Bob Ross, PA-C | Image Credit: APAC
How to Manage Aspirin-Exacerbated Respiratory Disease
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
AMG0001 Advances Healing in CLTI with David G. Armstrong, DPM, PhD, and Michael S. Conte, MD | Image Credit: Canva
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
© 2024 MJH Life Sciences

All rights reserved.